SCHEMBL10623398

SCHEMBL10623398

N#Cc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HTT P42858 2/20 0.60
BLM P54132 2/20 0.60
KDM4E B2RXH2 2/20 0.60
GAA P10253 1/20 0.60
TSHR P16473 1/20 0.60
ADORA3 P0DMS8 2/20 0.55
ADORA1 P30542 2/20 0.55
SLC29A1 Q99808 3/20 0.52
DPP4 P27487 1/20 0.52
MEN1 O00255 1/20 0.52
SLC28A1 O00337 1/20 0.52
MAP3K7 O43318 1/20 0.52
SLC28A2 O43868 1/20 0.52
GAPDH P04406 1/20 0.52
MAPK1 P28482 1/20 0.52
ADORA2A P29274 1/20 0.52
ADORA2B P29275 1/20 0.52
STAT6 P42226 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746201 0.86 ADORA3 (0.52) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL9699120 0.85 ADORA3 (0.51) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL11472440 0.85 TP53 (0.62) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL9619994 0.85 TP53 (0.62) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL9699971 0.85 ADORA3 (0.51) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL6934040 0.85 TP53 (0.62) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL9697576 0.83 ADORA3 (0.49) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL10623372 0.82 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2HTTBLMKDM4E
SCHEMBL10483440 0.81 SLC29A1 (0.69) ALDH1A1SMN1; SMN2HTTADORA3ADORA1
SCHEMBL9698667 0.81 ADORA3 (0.47) ALDH1A1SMN1; SMN2HTTBLMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0155164-B1 NOVEL CYANOIMIDAZOLE NUCLEOSIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-11-17 EP claimed
US-4728729-A ANTITUMOR, IMMUNOSUPPRESSANT SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1988-03-01 US claimed
EP-0155164-A2 Novel cyanoimidazole nucleoside derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1985-09-18 EP claimed
EP-0155164-B1 NOVEL CYANOIMIDAZOLE NUCLEOSIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-11-17 EP disclosed
US-4728729-A ANTITUMOR, IMMUNOSUPPRESSANT SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 1988-03-01 US disclosed
EP-0155164-A2 Novel cyanoimidazole nucleoside derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1985-09-18 EP disclosed